0

    540694

    ANG

    No Data Available

    Looking to invest in ANG Lifesciences India Ltd? Open a Demat account in minutes.

    ANG Lifesciences India Ltd Share Price Today

    Investment Returns

    Over 1 Month 0.34% Over 3 Months 33.56% Over 6 Months 44.63% Over 1 Year 28.49%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 48.80
    • P/E Ratio (TTM) -5.37
    • Beta 0.33
    • Book Value / share 43.04
    • Return on equity -7.33%
    • EPS (TTM) 0.00
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -2.66
    info icon alternate text

    ANG Lifesciences India Ltd Financials

    Open financial information
    Revenue
    Net income
    Particulars SEP 2026 (Values in Cr)
    Revenue 18.58
    Operating Expense 22.16
    Net Profit -2.66
    Net Profit Margin (%) -14.31
    Earnings Per Share (EPS) -2.01
    EBITDA -0.23
    Effective Tax Rate (%) 21.53
    Particulars JUN 2026 (Values in Cr)
    Revenue 13.96
    Operating Expense 18.66
    Net Profit -3.42
    Net Profit Margin (%) -24.49
    Earnings Per Share (EPS) -2.59
    EBITDA -1.26
    Effective Tax Rate (%) 24.16
    Particulars MAR 2026 (Values in Cr)
    Revenue 22.80
    Operating Expense 21.56
    Net Profit 1.10
    Net Profit Margin (%) 4.82
    Earnings Per Share (EPS) 0.90
    EBITDA 4.81
    Effective Tax Rate (%) 23.07
    Particulars DEC 2025 (Values in Cr)
    Revenue 18.30
    Operating Expense 23.43
    Net Profit -4.24
    Net Profit Margin (%) -23.16
    Earnings Per Share (EPS) -3.23
    EBITDA -1.92
    Effective Tax Rate (%) 14.85
    Particulars SEP 2025 (Values in Cr)
    Revenue 25.97
    Operating Expense 26.80
    Net Profit -0.80
    Net Profit Margin (%) -3.08
    Earnings Per Share (EPS) -0.60
    EBITDA 2.42
    Effective Tax Rate (%) -29.03
    Particulars MAR 2026 (Values in Cr)
    Revenue 91.60
    Operating Expense 97.52
    Net Profit -4.73
    Net Profit Margin (%) -5.16
    Earnings Per Share (EPS) -3.52
    EBITDA 7.34
    Effective Tax Rate (%) 8.86
    Particulars MAR 2025 (Values in Cr)
    Revenue 89.91
    Operating Expense 105.28
    Net Profit -10.34
    Net Profit Margin (%) -11.50
    Earnings Per Share (EPS) -7.86
    EBITDA 0.62
    Effective Tax Rate (%) 20.01
    Particulars MAR 2024 (Values in Cr)
    Revenue 131.37
    Operating Expense 139.34
    Net Profit -8.65
    Net Profit Margin (%) -6.58
    Earnings Per Share (EPS) -6.48
    EBITDA 8.21
    Effective Tax Rate (%) 2.48
    Particulars MAR 2023 (Values in Cr)
    Revenue 207.01
    Operating Expense 214.76
    Net Profit -0.66
    Net Profit Margin (%) -0.31
    Earnings Per Share (EPS) 0.04
    EBITDA 20.91
    Effective Tax Rate (%) 131.88
    Particulars MAR 2022 (Values in Cr)
    Revenue 348.67
    Operating Expense 296.56
    Net Profit 39.71
    Net Profit Margin (%) 11.38
    Earnings Per Share (EPS) 38.51
    EBITDA 66.03
    Effective Tax Rate (%) 25.16
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 36.91
    ROE % -16.46
    ROCE % -2.29
    Total Debt to Total Equity 1.39
    EBITDA Margin 3.33
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 45.40
    ROE % -17.70
    ROCE % -4.41
    Total Debt to Total Equity 1.11
    EBITDA Margin 0.12
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 54.82
    ROE % -10.56
    ROCE % 1.43
    Total Debt to Total Equity 0.88
    EBITDA Margin 7.28
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 62.43
    ROE % -0.21
    ROCE % 8.31
    Total Debt to Total Equity 0.87
    EBITDA Margin 10.74
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 76.28
    ROE % 48.13
    ROCE % 35.05
    Total Debt to Total Equity 0.92
    EBITDA Margin 19.42
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 47.37
    ROE % -7.33
    ROCE % 1.15
    Total Debt to Total Equity 1.06
    EBITDA Margin 8.33
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 50.88
    ROE % -14.37
    ROCE % -3.80
    Total Debt to Total Equity 0.90
    EBITDA Margin 1.08
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 58.74
    ROE % -8.72
    ROCE % 1.71
    Total Debt to Total Equity 0.71
    EBITDA Margin 7.78
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 61.91
    ROE % -0.46
    ROCE % 7.81
    Total Debt to Total Equity 0.69
    EBITDA Margin 9.99
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 76.00
    ROE % 63.62
    ROCE % 49.10
    Total Debt to Total Equity 0.83
    EBITDA Margin 19.07
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 3.78
    Total Assets 208.94
    Total Liabilities 208.94
    Total Equity 52.88
    Share Outstanding 1
    Price to Book Ratio 0.39
    Return on Assets (%) -5.30
    Return on Capital (%) -8.5
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.63
    Total Assets 229.59
    Total Liabilities 229.59
    Total Equity 63.97
    Share Outstanding 1
    Price to Book Ratio 0.45
    Return on Assets (%) -5.40
    Return on Capital (%) -8.6
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.73
    Total Assets 242.43
    Total Liabilities 242.43
    Total Equity 76.27
    Share Outstanding 1
    Price to Book Ratio 0.77
    Return on Assets (%) -4.18
    Return on Capital (%) -6.97
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.17
    Total Assets 277.66
    Total Liabilities 277.66
    Total Equity 86.21
    Share Outstanding 1
    Price to Book Ratio 1.23
    Return on Assets (%) -0.09
    Return on Capital (%) -0.17
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.65
    Total Assets 291.03
    Total Liabilities 291.03
    Total Equity 83.76
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 13.85
    Return on Capital (%) 25.08
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 3.57
    Total Assets 189.91
    Total Liabilities 189.91
    Total Equity 62.21
    Share Outstanding 1
    Price to Book Ratio 0.39
    Return on Assets (%) -2.48
    Return on Capital (%) -3.72
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 3.55
    Total Assets 208.66
    Total Liabilities 208.66
    Total Equity 66.80
    Share Outstanding 1
    Price to Book Ratio 0.45
    Return on Assets (%) -4.95
    Return on Capital (%) -7.68
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 5.49
    Total Assets 217.42
    Total Liabilities 217.42
    Total Equity 77.07
    Share Outstanding 1
    Price to Book Ratio 0.77
    Return on Assets (%) -3.97
    Return on Capital (%) -6.51
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 6.05
    Total Assets 252.50
    Total Liabilities 252.50
    Total Equity 85.53
    Share Outstanding 1
    Price to Book Ratio 1.23
    Return on Assets (%) -0.26
    Return on Capital (%) -0.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 6.58
    Total Assets 268.68
    Total Liabilities 268.68
    Total Equity 83.48
    Share Outstanding 1
    Price to Book Ratio 3.09
    Return on Assets (%) 14.78
    Return on Capital (%) 27.49
    Particulars MAR 2026 (Values in Cr)
    Net Income -13.01
    Cash from Operations 11.07
    Cash from Investing 1.04
    Cash from Financing -11.74
    Net change in Cash 0.33
    Free Cash Flow 11.51
    Particulars MAR 2025 (Values in Cr)
    Net Income -15.70
    Cash from Operations 3.97
    Cash from Investing -1.58
    Cash from Financing 1.68
    Net change in Cash -0.16
    Free Cash Flow 7.72
    Particulars MAR 2024 (Values in Cr)
    Net Income -10.71
    Cash from Operations 3.91
    Cash from Investing 19.89
    Cash from Financing -10.40
    Net change in Cash 0.00
    Free Cash Flow 9.48
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.62
    Cash from Operations 29.83
    Cash from Investing -9.32
    Cash from Financing -17.07
    Net change in Cash -0.02
    Free Cash Flow 40.28
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.50
    Cash from Operations 25.24
    Cash from Investing -44.40
    Cash from Financing 19.92
    Net change in Cash 0.23
    Free Cash Flow 66.58
    Particulars MAR 2026 (Values in Cr)
    Net Income -5.19
    Cash from Operations 13.76
    Cash from Investing -3.32
    Cash from Financing -10.18
    Net change in Cash 0.20
    Free Cash Flow 17.89
    Particulars MAR 2025 (Values in Cr)
    Net Income -12.93
    Cash from Operations 1.89
    Cash from Investing -1.62
    Cash from Financing 3.91
    Net change in Cash 0.00
    Free Cash Flow 6.01
    Particulars MAR 2024 (Values in Cr)
    Net Income -8.86
    Cash from Operations 0.26
    Cash from Investing 20.01
    Cash from Financing -7.00
    Net change in Cash -0.11
    Free Cash Flow 5.70
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.06
    Cash from Operations 29.36
    Cash from Investing -9.34
    Cash from Financing -16.74
    Net change in Cash -0.08
    Free Cash Flow 39.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.06
    Cash from Operations 27.97
    Cash from Investing -42.50
    Cash from Financing 15.28
    Net change in Cash 0.17
    Free Cash Flow 67.31
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 39.00 19.31 1.82 298.87 23.12 49.98
    BLISS GVS PHARMA LTD 674.30 44.10 5.55 7173.47 140.85 744.75
    CIPLA LTD 1420.00 36.94 3.24 114720.11 1165.55 1539.25
    FERMENTA BIOTECH LTD. 455.60 28.87 3.20 1340.88 256.40 582.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENTERPRISES L 39.00 66.10 5.02 298.87 23.12 49.98
    AMRUTANJAN HEALTH CARE LTD. 515.90 22.76 3.88 1491.50 476.85 712.90
    ASTRAZENECA PHARMA INDIA LTD. 6006.95 79.78 17.08 15017.38 5660.00 9449.00
    BLISS GVS PHARMA LTD 674.30 53.56 5.66 7173.47 140.85 744.75

    ANG Lifesciences India Ltd shareholding pattern

    Holding
    29.39%
    70.6%
    44.88%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    ANG Lifesciences India Ltd Technicals Summary

    37.35 -1.39 redarrow
    red-green-graph indicator
    6 Bearish
    10 Bullish
    • 5 Days 38.20
    • 26 Days 36.80
    • 10 Days 37.70
    • 50 Days 36.00
    • 12 Days 37.50
    • 100 Days 34.50
    • 20 Days 37.00
    • 200 Days 32.80
    38.50 PIVOT
    First Support 37.09 First Resistance 39.29 Second Support 36.30 Second Resistance 40.70 Third Support 34.89 Third Resistance 41.49
    RSI 53.41 ADX 30.99 MACD 0.76 Williams % R -41.29 Commodity Channel Index (CCI) 74.24
    Date 2026-11-18 Week 8914.00 Same Day 2692.00 Month 5431.00
    1 Year 0.33 3 Year 0.23
    Over 1 Month
    0.34% down
    Over 1 Year
    28.49% down
    Over 3 Months
    33.56% down
    Over 3 Years
    -16.54% down
    Over 6 Months
    44.63% down
    Over 5 Years
    -38.77% down

    ANG Lifesciences India Ltd Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    27 Nov 2026 0.75 Final 27 Nov 2026 Equity shares
    25 Nov 2026 0.6 Interim 25 Nov 2026 Equity shares
    23 Nov 2026 0.02 Interim 23 Nov 2026 Equity shares
    20 Nov 2026 1.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 0.3 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 12.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 1.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 0.5 Interim 1 20 Nov 2026 Equity shares
    20 Nov 2026 0.45 Interim 2 20 Nov 2026 Equity shares
    20 Nov 2026 0.05 Interim 1 20 Nov 2026 Equity shares
    20 Nov 2026 2.5 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 7.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 0.4 Interim 2 20 Nov 2026 Equity shares
    20 Nov 2026 20.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 1.0 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 0.5 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 1.0 Interim 1 20 Nov 2026 Equity shares
    20 Nov 2026 1.5 Interim 20 Nov 2026 Equity shares
    20 Nov 2026 0.1 Interim 20 Nov 2026 Equity shares
    19 Nov 2026 20.0 Interim 19 Nov 2026 Equity shares
    19 Nov 2026 1.0 Interim 19 Nov 2026 Equity shares
    19 Nov 2026 1.25 Interim 2 19 Nov 2026 Equity shares
    19 Nov 2026 0.8 Interim 2 19 Nov 2026 Equity shares
    19 Nov 2026 1.0 Interim 2 19 Nov 2026 Equity shares
    18 Nov 2026 18.0 Interim 2 18 Nov 2026 Equity shares
    18 Nov 2026 1.0 Interim 2 18 Nov 2026 Equity shares
    18 Nov 2026 150.0 Interim 2 18 Nov 2026 Equity shares
    18 Nov 2026 0.65 Interim 18 Nov 2026 Equity shares
    18 Nov 2026 1.0 Interim 1 18 Nov 2026 Equity shares
    18 Nov 2026 3.25 Final 18 Nov 2026 Equity shares
    18 Nov 2026 0.5 Interim 18 Nov 2026 Equity shares
    18 Nov 2026 2.3 Final 18 Nov 2026 Equity shares
    18 Nov 2026 0.5 Interim 18 Nov 2026 Equity shares
    17 Nov 2026 3.0 Interim 17 Nov 2026 Equity shares
    17 Nov 2026 3.0 Interim 17 Nov 2026 Equity shares
    17 Nov 2026 4.1 Interim 2 17 Nov 2026 Equity shares
    17 Nov 2026 7.0 Interim 17 Nov 2026 Equity shares
    17 Nov 2026 3.4596 Final 17 Nov 2026 Equity shares
    17 Nov 2026 3.0 Final 17 Nov 2026 Equity shares
    16 Nov 2026 0.9 Interim 16 Nov 2026 Equity shares
    16 Nov 2026 4.0 Interim 16 Nov 2026 Equity shares
    16 Nov 2026 6.0 Interim 2 16 Nov 2026 Equity shares
    16 Nov 2026 3.0 Interim 16 Nov 2026 Equity shares
    16 Nov 2026 0.15 Interim 16 Nov 2026 Equity shares
    13 Nov 2026 14.4 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 6.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.35 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.05 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 11.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 0.75 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 10.0 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 1.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 3.25 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 0.1 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 5.0 Interim 1 13 Nov 2026 Equity shares
    13 Nov 2026 0.01 Interim 2 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 0.5 Interim 13 Nov 2026 Equity shares
    13 Nov 2026 2.0 Interim 13 Nov 2026 Equity shares
    12 Nov 2026 90.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 19.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 10.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 2.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 40.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 1.5 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 8.0 Interim 1 12 Nov 2026 Equity shares
    12 Nov 2026 3.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 5.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 0.05 Interim 2 12 Nov 2026 Equity shares
    12 Nov 2026 1.0 Interim 12 Nov 2026 Equity shares
    12 Nov 2026 2.529 Final 12 Nov 2026 Equity shares
    12 Nov 2026 0.5 Interim 1 12 Nov 2026 Equity shares
    12 Nov 2026 2.9585 Final 12 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 2 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.5 Special 11 Nov 2026 Equity shares
    11 Nov 2026 1.65 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 4.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 0.6 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 5.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 7.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 2.5 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 6.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 18.0 Interim 11 Nov 2026 Equity shares
    11 Nov 2026 1.35 Interim 2 11 Nov 2026 Equity shares
    Ex-Date Ex-Bonus Ratio
    13 Nov 2026 13 Nov 2026 1:1
    13 Nov 2026 13 Nov 2026 3:2
    04 Nov 2026 04 Nov 2026 1:1
    02 Nov 2026 02 Nov 2026 2:5
    23 Oct 2026 23 Oct 2026 1:4
    15 Oct 2026 15 Oct 2026 1:2
    12 Oct 2026 12 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    09 Oct 2026 09 Oct 2026 1:1
    07 Oct 2026 07 Oct 2026 10:1
    07 Oct 2026 07 Oct 2026 2:1
    01 Oct 2026 01 Oct 2026 1:1
    01 Oct 2026 01 Oct 2026 1:1
    28 Sep 2026 28 Sep 2026 1:1
    24 Sep 2026 24 Sep 2026 1:1
    11 Sep 2026 11 Sep 2026 1:1
    12 Sep 2026 11 Sep 2026 1:1
    04 Sep 2026 04 Sep 2026 7:24
    24 Aug 2026 24 Aug 2026 1:1
    24 Aug 2026 24 Aug 2026 1:1
    21 Aug 2026 21 Aug 2026 2:1
    20 Aug 2026 20 Aug 2026 1:2
    20 Aug 2026 20 Aug 2026 3:1
    17 Aug 2026 17 Aug 2026 5:1
    31 Jul 2026 31 Jul 2026 1:5
    28 Jul 2026 28 Jul 2026 2:5
    24 Jul 2026 24 Jul 2026 1:2
    16 Jul 2026 16 Jul 2026 2:1
    10 Jul 2026 10 Jul 2026 1:3
    10 Jul 2026 10 Jul 2026 2:1
    07 Jul 2026 07 Jul 2026 5:1
    02 Jul 2026 02 Jul 2026 2:1
    24 Jun 2026 24 Jun 2026 5:1
    24 Jun 2026 24 Jun 2026 10:1
    19 Jun 2026 19 Jun 2026 2:9
    17 Jun 2026 17 Jun 2026 1:3
    16 Jun 2026 16 Jun 2026 1:1
    12 Jun 2026 12 Jun 2026 1:3
    10 Jun 2026 10 Jun 2026 3:1
    04 Jun 2026 04 Jun 2026 1:2
    03 Jun 2026 03 Jun 2026 1:1
    29 May 2026 29 May 2026 1:1
    26 May 2026 26 May 2026 1:10
    25 May 2026 25 May 2026 6:1
    15 May 2026 15 May 2026 1:6
    15 May 2026 15 May 2026 1:1
    12 May 2026 12 May 2026 3:2
    08 May 2026 08 May 2026 6:1
    24 Apr 2026 24 Apr 2026 4:1
    24 Apr 2026 24 Apr 2026 1:1
    10 Apr 2026 10 Apr 2026 5:7
    07 Apr 2026 07 Apr 2026 3:1
    02 Apr 2026 02 Apr 2026 1:2
    03 Apr 2026 02 Apr 2026 1:2
    01 Apr 2026 30 Mar 2026 3:1
    01 Apr 2026 30 Mar 2026 1:1
    27 Mar 2026 27 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    24 Mar 2026 24 Mar 2026 1:1
    20 Mar 2026 20 Mar 2026 3:1
    13 Mar 2026 13 Mar 2026 2:1
    13 Mar 2026 13 Mar 2026 1:1
    10 Mar 2026 10 Mar 2026 1:10
    09 Mar 2026 09 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 4:1
    06 Mar 2026 06 Mar 2026 1:10
    06 Mar 2026 06 Mar 2026 1:1
    06 Mar 2026 06 Mar 2026 1:2
    02 Mar 2026 02 Mar 2026 7:5
    27 Feb 2026 27 Feb 2026 3:1
    19 Feb 2026 18 Feb 2026 1:1
    17 Feb 2026 17 Feb 2026 1:2
    13 Feb 2026 13 Feb 2026 1:10
    14 Feb 2026 13 Feb 2026 2:1
    23 Jan 2026 23 Jan 2026 5:40
    16 Jan 2026 16 Jan 2026 1:2
    13 Jan 2026 13 Jan 2026 4:1
    09 Jan 2026 09 Jan 2026 1:10
    05 Jan 2026 05 Jan 2026 1:10
    02 Jan 2026 02 Jan 2026 1:1
    02 Jan 2026 02 Jan 2026 23:1
    02 Jan 2026 02 Jan 2026 4:1
    31 Dec 2025 31 Dec 2025 3:1
    26 Dec 2025 26 Dec 2025 1:1
    24 Dec 2025 24 Dec 2025 2:1
    19 Dec 2025 19 Dec 2025 1:1
    19 Dec 2025 19 Dec 2025 4:1
    18 Dec 2025 18 Dec 2025 3:1
    17 Dec 2025 17 Dec 2025 5:11
    15 Dec 2025 15 Dec 2025 1:1
    12 Dec 2025 12 Dec 2025 1:1
    08 Dec 2025 08 Dec 2025 1:1
    05 Dec 2025 05 Dec 2025 24:1
    05 Dec 2025 05 Dec 2025 5:2
    05 Dec 2025 05 Dec 2025 1:1
    28 Nov 2025 28 Nov 2025 2:1
    26 Nov 2025 26 Nov 2025 1:1
    21 Nov 2025 21 Nov 2025 2:10
    19 Nov 2025 19 Nov 2025 3:5
    Ex-Date Old FV NEW FV Record Date
    10 Dec 2026 10.0 2.0 10 Dec 2026
    30 Nov 2026 10.0 2.0 30 Nov 2026
    27 Nov 2026 5.0 2.0 27 Nov 2026
    16 Nov 2026 10.0 1.0 16 Nov 2026
    06 Nov 2026 5.0 1.0 06 Nov 2026
    06 Nov 2026 2.0 10.0 06 Nov 2026
    05 Nov 2026 10.0 1.0 05 Nov 2026
    30 Oct 2026 10.0 5.0 30 Oct 2026
    30 Oct 2026 10.0 1.0 30 Oct 2026
    29 Oct 2026 10.0 1.0 29 Oct 2026
    26 Oct 2026 10.0 5.0 26 Oct 2026
    23 Oct 2026 10.0 2.0 23 Oct 2026
    22 Oct 2026 10.0 1.0 22 Oct 2026
    19 Oct 2026 10.0 1.0 19 Oct 2026
    16 Oct 2026 5.0 1.0 16 Oct 2026
    16 Oct 2026 5.0 10.0 16 Oct 2026
    15 Oct 2026 10.0 2.0 15 Oct 2026
    13 Oct 2026 1.0 10.0 13 Oct 2026
    08 Oct 2026 10.0 2.0 08 Oct 2026
    06 Oct 2026 10.0 5.0 06 Oct 2026
    25 Sep 2026 10.0 5.0 25 Sep 2026
    25 Sep 2026 10.0 1.0 25 Sep 2026
    22 Sep 2026 10.0 2.0 22 Sep 2026
    18 Sep 2026 10.0 2.0 18 Sep 2026
    18 Sep 2026 10.0 1.0 18 Sep 2026
    04 Sep 2026 10.0 2.0 04 Sep 2026
    04 Sep 2026 10.0 1.0 04 Sep 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 1.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    28 Aug 2026 10.0 2.0 28 Aug 2026
    25 Aug 2026 10.0 1.0 26 Aug 2026
    24 Aug 2026 2.0 1.0 24 Aug 2026
    18 Aug 2026 2.0 1.0 18 Aug 2026
    07 Aug 2026 10.0 5.0 07 Aug 2026
    05 Aug 2026 10.0 1.0 05 Aug 2026
    31 Jul 2026 10.0 5.0 31 Jul 2026
    31 Jul 2026 10.0 1.0 31 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    24 Jul 2026 10.0 2.0 24 Jul 2026
    21 Jul 2026 5.0 2.0 21 Jul 2026
    20 Jul 2026 10.0 2.0 20 Jul 2026
    17 Jul 2026 10.0 2.0 17 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    10 Jul 2026 10.0 1.0 10 Jul 2026
    08 Jul 2026 10.0 1.0 08 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 1.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    03 Jul 2026 10.0 2.0 03 Jul 2026
    19 Jun 2026 10.0 1.0 19 Jun 2026
    12 Jun 2026 10.0 2.0 12 Jun 2026
    05 Jun 2026 10.0 1.0 05 Jun 2026
    29 May 2026 10.0 2.0 29 May 2026
    26 May 2026 10.0 2.0 26 May 2026
    26 May 2026 10.0 1.0 26 May 2026
    22 May 2026 10.0 5.0 22 May 2026
    15 May 2026 10.0 5.0 15 May 2026
    05 May 2026 10.0 1.0 05 May 2026
    30 Apr 2026 100.0 1.0 30 Apr 2026
    30 Apr 2026 1.0 10.0 30 Apr 2026
    24 Apr 2026 10.0 2.0 24 Apr 2026
    24 Apr 2026 10.0 1.0 24 Apr 2026
    17 Apr 2026 10.0 1.0 17 Apr 2026
    02 Apr 2026 2.0 1.0 03 Apr 2026
    27 Mar 2026 10.0 5.0 27 Mar 2026
    25 Mar 2026 10.0 1.0 26 Mar 2026
    25 Mar 2026 10.0 1.0 25 Mar 2026
    13 Mar 2026 10.0 2.0 13 Mar 2026
    09 Mar 2026 10.0 5.0 09 Mar 2026
    06 Mar 2026 10.0 2.0 06 Mar 2026
    06 Mar 2026 10.0 5.0 06 Mar 2026
    06 Mar 2026 100.0 1.0 06 Mar 2026
    05 Mar 2026 10.0 1.0 05 Mar 2026
    02 Mar 2026 10.0 5.0 02 Mar 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    27 Feb 2026 10.0 1.0 27 Feb 2026
    26 Feb 2026 10.0 1.0 26 Feb 2026
    25 Feb 2026 10.0 1.0 25 Feb 2026
    20 Feb 2026 10.0 2.0 20 Feb 2026
    13 Feb 2026 10.0 2.0 14 Feb 2026
    13 Feb 2026 10.0 1.0 13 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    06 Feb 2026 10.0 2.0 06 Feb 2026
    06 Feb 2026 10.0 1.0 06 Feb 2026
    22 Jan 2026 5.0 1.0 22 Jan 2026
    16 Jan 2026 10.0 1.0 16 Jan 2026
    14 Jan 2026 10.0 2.0 15 Jan 2026
    14 Jan 2026 5.0 1.0 14 Jan 2026
    12 Jan 2026 10.0 5.0 12 Jan 2026
    08 Jan 2026 10.0 1.0 08 Jan 2026
    02 Jan 2026 10.0 2.0 02 Jan 2026
    29 Dec 2025 1.0 10.0 29 Dec 2025
    26 Dec 2025 10.0 2.0 26 Dec 2025
    22 Dec 2025 10.0 5.0 22 Dec 2025

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of ANG Lifesciences India Ltd?

    ANG Lifesciences India Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.35 as on Nov 19 2026 10:37 AM.

    What is the Market Cap of ANG Lifesciences India Ltd Share?

    The market cap of ANG Lifesciences India Ltd for NSE ₹ 0.00 & for BSE ₹ 49.46 as on Nov 19 2026 10:37 AM.

    What is the 52 Week High and Low of ANG Lifesciences India Ltd?

    The 52 Week High and Low of ANG Lifesciences India Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 49.69 and ₹ 17.63.

    What is 1 year return for ANG Lifesciences India Ltd?

    The 1 year returns on the stock has been 28.49%.

    What is the P/E Ratio of ANG Lifesciences India Ltd Share?

    As on Nov 19 2026 10:37 AM the price-to-earnings (PE) ratio for ANG Lifesciences India Ltd share is -5.37.

    What is the PB ratio of ANG Lifesciences India Ltd Share?

    As on Nov 19 2026 10:37 AM, the price-to-book (PB) ratio for ANG Lifesciences India Ltd share is 43.04.

    How to Buy ANG Lifesciences India Ltd Share?

    You can trade in ANG Lifesciences India Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy ANG Lifesciences India Ltd Share on Bajaj Broking App?

    To buy ANG Lifesciences India Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “ANG Lifesciences India Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    Bajaj Broking Regulatory Details

    SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | MCX Member ID: 57680 | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403 | APMI APRN : APRN04289.

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |

    Open Your Free Demat Account

    Access Research Backed Stock Recommendations

    +91

    |